Prime editing: A potential treatment option for ß-thalassemia.

Arif, Taqdees; Farooq, Aroosa; Ahmad, Fridoon Jawad; Akhtar, Muhammad; Choudhery, Mahmood S

Arif, Taqdees; Farooq, Aroosa; Ahmad, Fridoon Jawad; Akhtar, Muhammad; Choudhery, Mahmood S.

Afiliação

Arif T; Department of Human Genetics and Molecular Biology, University of Health Sciences Lahore, Lahore, Punjab, Pakistan.
Farooq A; Department of Human Genetics and Molecular Biology, University of Health Sciences Lahore, Lahore, Punjab, Pakistan.
Ahmad FJ; Department of Human Genetics and Molecular Biology, University of Health Sciences Lahore, Lahore, Punjab, Pakistan.
Akhtar M; School of Biological Sciences, University of Punjab Lahore, Lahore, Punjab, Pakistan.
Choudhery MS; Department of Human Genetics and Molecular Biology, University of Health Sciences Lahore, Lahore, Punjab, Pakistan.

Cell Biol Int ; 47(4): 699-713, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36480796

Assuntos

Sistemas CRISPR-Cas; Talassemia beta; Humanos; Talassemia beta/genética; Edição de Genes; Genoma

Palavras-chave

CRISR; base editors; gene editing; prime editing; ß-thalassemia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talassemia beta / Sistemas CRISPR-Cas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google